Naturite Agro (538926)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹83.75 |
| Market Cap | ₹45.56 Cr |
| P/E Ratio | 456.27 |
| ROCE | -16.07% |
| ROE | 2.19% |
| Dividend Yield | 0% |
| Profit Growth | 147.73% |
| Debt/Equity | — |
| Sales Growth | 940% |
| 52-Week Range | ₹121 — ₹365 |
| Sector | Agricultural Food & other Products |
| Book Value | ₹25.03 |
Strengths
- Sales growth of 940% shows strong recent topline expansion, albeit from a low base.
- Profit growth of 147.73% is positive and directionally encouraging.
- Piotroski F-Score of 6/9 suggests no immediate distress across several financial metrics.
- Book value of ₹25.03 provides some tangible asset backing, and reported debt/equity is not an obvious overhang.
Concerns
- P/E of 456.27 with latest quarterly net profit of ₹0 Cr means there is no real earnings support for the price.
- ROCE of -16.07% shows capital is being destroyed at the operating level; ROE of 2.19% is too low to justify a 3.35 P/B.
- Current price ₹83.75 is below the stated 52-week low of ₹121.00, suggesting severe repricing or weak data transparency.
- Zero dividend yield and undisclosed promoter holding add to the lack of investor protection and income downside.
AI Analysis
Ben Graham taught me that price is what you pay, quality is what you get. At Naturite Agro, I get very little quality for a very high price. The market cap is ₹46 Cr, but I am asked to pay 456.27 times earnings. What earnings? The latest quarter shows sales of ₹6 Cr and a net profit that rounds to ₹0 Cr. A P/E of 456 on near-zero profit is not valuation; it is speculation. Yes, sales grew 940% and profit grew 147.73%, but high percentage growth from a microscopic base means little. The operating picture is worse: ROCE is -16.07%, meaning capital employed here is destroying value. ROE of 2.19% is barely above what I could earn in a bank, with far less risk. Book value is ₹25.03, yet the shares trade at ₹83.75, 3.35 times book. For that premium, I need a wide moat and high returns—I see neither. The 52-week range is odd: ₹121.00 to ₹398.35, yet the current price is ₹83.75, below that low. Either the tape is stale or the market has repriced the story violently. Neither gives me confidence. Dividend yield is 0.00%, so I am not paid to wait. Debt-to-equity is not disclosed; promoter holding is not disclosed. With that much opacity, Graham would call this a speculative venture. The only mildly encouraging facts are the Piotroski F-Score of 6/9 and the positive profit growth. But a 6/9 score is not a moat. The quoted PEG 0.84 assumes the 147.73% profit growth is sustainable, yet the most recent quarter had zero net profit. That is arithmetic, not insight. If this is a genuine turnaround, the burden of proof is on management. I need years of positive earnings, positive ROCE, and honest disclosure before I consider putting a rupee here. For now, this goes in the 'too hard' pile.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer